Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01882969

Ligand	Ligand name	Chain	PDB	Tanimoto
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	A	2J0J	0.73
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	B	2J0M	0.73
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	A,B	2J0K	0.73
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	A	1YVJ	0.73
4ST	1,2,3,4-TETRAHYDROGEN-STAUROSPORINE	A,B,C	2HZ4	0.73
288	5-CHLORO-1H-INDOLE-2-CARBOXYLIC ACID{[CYCLOPENTYL-(2-HYDROXY-ETHYL)-CARBAMOYL]-METHYL}-AMIDE	A,B	1XOI	0.7
19B	4-methyl-N-(3-morpholin-4-ylphenyl)-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)benzamide	A	3E93	0.71
1TQ	6-(FORMYLAMINO)-7-HYDROXY-L-TRYPTOPHAN	D,H	2OK6	0.7
1TQ	6-(FORMYLAMINO)-7-HYDROXY-L-TRYPTOPHAN	D,H	2I0R	0.7
1ST	(5S,6R,7R,9R)-12-HYDROXY-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE	1	2HY8	0.7
117	7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]- 3,5-DIHYDROXY-HEPTANOIC ACID	A,B,C,D	1HWK	0.7
547	2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE	A	2OF2	0.71
4IN	4-AMINO-L-TRYPTOPHAN	A,B	2HXX	0.71
4IN	4-AMINO-L-TRYPTOPHAN	A	1OXF	0.71
627	N-[(3E)-5-[(2R)-2-METHOXY-2-PHENYLACETYL]PYRROLO[3,4-C]PYRAZOL-3(5H)-YLIDENE]-4-(4-METHYLPIPERAZIN-1-YL)BENZAMIDE	A,B	2J50	0.72
627	N-[(3E)-5-[(2R)-2-METHOXY-2-PHENYLACETYL]PYRROLO[3,4-C]PYRAZOL-3(5H)-YLIDENE]-4-(4-METHYLPIPERAZIN-1-YL)BENZAMIDE	A,B	2V7A	0.72
2S3	(2S)-2-(1H-indol-3-yl)pentanoic acid	B	3C6P	0.71
1IQ	2-(4-ISOPROPYL-4-METHYL-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-2-YL)QUINOLINE-3-CARBOXYLIC ACID	A	1Z8N	0.74
330	9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE	A	2IO6	0.72
2S8	(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid	B	3C6N	0.72
669	1-(5-CARBOXYPENTYL)-5-(2,6-DICHLOROBENZYLOXY)-1H-INDOLE-2-CARBOXYLIC ACID	A	1MZS	0.71
3HI	(3R,5R)-7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-5-(1-methylethyl)-3-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid	B,C,D	3CCT	0.7
3LG	(5-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)-6-OXOPIPERAZIN-2-YL]METHOXY}-1H-INDOL-1-YL)ACETIC ACID	B	2G26	0.71
4LG	METHYL (6-{[(2R)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)-6-OXOPIPERAZIN-2-YL]METHOXY}-1H-INDOL-1-YL)ACETATE	A,B	2G27	0.71
110	3-(4-AMINO-CYCLOHEXYL)-2-HYDROXY-3-[(4-OXO-2-PHENYLMETHANESULFONYL-1,2,3,4-TETRAHYDRO-PYRROLO[1,2-A]PYRAZINE-6-CARBONYL)-AMINO]-PROPIONIC ACID BUTYL ESTER	A	1G37	0.72
2S2	(2S)-2-(1H-indol-3-yl)hexanoic acid	B	3C6O	0.72
3CS	3-[3-(3,3-DIMETHYLBUTANOYL)-1-(4-IODOBENZYL)-5-(QUINOLIN-2-YLMETHOXY)-1H-INDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID	A,B,C,D,E,F	2Q7R	0.72